title: Reducing early exposure to calcineurin inhibitors: the key factor for a successful renal sparing strategy.
authors.forename: M
authors.initials: M
authors.lastname: Rodríguez-Perálvarez
authors.forename: G
authors.initials: G
authors.lastname: Germani
authors.forename: T
authors.initials: T
authors.lastname: Darius
authors.forename: J
authors.initials: J
authors.lastname: Lerut
authors.forename: E
authors.initials: E
authors.lastname: Tsochatzis
authors.forename: A K
authors.initials: AK
authors.lastname: Burroughs
mesh_terms: D065095:Calcineurin Inhibitors; D000068338:Everolimus; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016031:Liver Transplantation; D008297:Male; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus